Daclatasvir Dihydrochloride and Erythromycin and sulfisoxazole
Determining the interaction of Daclatasvir Dihydrochloride and Erythromycin and sulfisoxazole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: erythromycin / sulfisoxazole
Brand name:
Synonyms: Erythromycin and sulfisoxazole (Oral), Erythromycin and Sulfisoxazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Erythromycin Base Filmtab
- Daclatasvir Dihydrochloride-Erythromycin Capsules
- Daclatasvir Dihydrochloride-Erythromycin Delayed-Release Tablet
- Daclatasvir Dihydrochloride-Erythromycin Delayed-Release Tablets and Capsules
- Daclatasvir Dihydrochloride-Erythromycin Ethyl Succinate Tablets
- Daclatasvir Dihydrochloride-Erythromycin Filmtabs
- Erythromycin and sulfisoxazole-Daclizumab
- Erythromycin and sulfisoxazole-Daclizumab Subcutaneous
- Erythromycin and sulfisoxazole-Dacogen
- Erythromycin and sulfisoxazole-Dacomitinib
- Erythromycin and sulfisoxazole-Dactinomycin
- Erythromycin and sulfisoxazole-Dactinomycin Injection